Pages that link to "Q51552633"
Jump to navigation
Jump to search
The following pages link to Peter Gibbs (Q51552633):
Displaying 50 items.
- Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer (Q21144952) (← links)
- Cancer classification using the Immunoscore: a worldwide task force (Q21245495) (← links)
- Towards the introduction of the 'Immunoscore' in the classification of malignant tumours (Q27026489) (← links)
- SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer (Q28278952) (← links)
- Detection of circulating tumor DNA in early- and late-stage human malignancies (Q29615778) (← links)
- Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study (Q30579114) (← links)
- Linking data from hospital and cancer registry databases: should this be standard practice? (Q33449871) (← links)
- Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. (Q33555345) (← links)
- Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer (Q33706508) (← links)
- Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). (Q33813216) (← links)
- BioGrid Australia facilitates collaborative medical and bioinformatics research across hospitals and medical research institutes by linking data from diverse disease and data types (Q33817278) (← links)
- Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces. (Q33888509) (← links)
- Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data (Q34007614) (← links)
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer (Q34062558) (← links)
- PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. (Q34184024) (← links)
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer (Q34533164) (← links)
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer (Q34628085) (← links)
- Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX s (Q34894115) (← links)
- Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. (Q34946877) (← links)
- The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. (Q35160866) (← links)
- A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer (Q35187723) (← links)
- Blood-based protein biomarker panel for the detection of colorectal cancer (Q35202822) (← links)
- Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients (Q35620994) (← links)
- Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13 (Q35688605) (← links)
- Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion (Q36531671) (← links)
- Cytosine methylation profiling of cancer cell lines. (Q36534546) (← links)
- Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation (Q36551145) (← links)
- Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer. (Q36968386) (← links)
- DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers (Q37020817) (← links)
- Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer. (Q37093977) (← links)
- Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis. (Q37209240) (← links)
- Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice? (Q37476887) (← links)
- Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey (Q37477083) (← links)
- Surgical oncology issues in locally advanced rectal cancer. (Q37980472) (← links)
- Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors. (Q38023976) (← links)
- A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases. (Q38169587) (← links)
- Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results? (Q38236794) (← links)
- Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors (Q38241076) (← links)
- Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013. (Q38241395) (← links)
- Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria (Q38565991) (← links)
- Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care. (Q40354587) (← links)
- Comparing oncological outcomes of laparoscopic versus open surgery for colon cancer: Analysis of a large prospective clinical database. (Q41355519) (← links)
- Guesstimates are not good enough for determining what is happening in routine care. (Q42552253) (← links)
- Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs. (Q42871709) (← links)
- An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer. (Q43451259) (← links)
- Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer. (Q43510126) (← links)
- PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17. (Q43562170) (← links)
- Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives? (Q43649885) (← links)
- Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. (Q43833101) (← links)
- Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia. (Q44488353) (← links)